John Robert Wilson, Director at Marker Therapeutics, holds 7.80M shares in Marker Therapeutics (Ticker: MRKR), holds 5.36M shares in AlloVir (Ticker: ALVR). Most recently, John Robert Wilson Bought ― shares of Marker Therapeutics on Mar 18, 2021 for an estimated value of 3.00M.